Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 03-2014 | 12-2013 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 66,680 | N/A | N/A |
| Receivables | 3,150 | N/A | N/A |
| Other current assets | 830 | 0 | 0 |
| TOTAL | $70,660 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 5,920 | N/A | N/A |
| Other Non-Current Assets | 4,820 | 0 | 0 |
| TOTAL | $10,740 | $N/A | $N/A |
| Total Assets | $77,990 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 6,580 | 0 | 0 |
| Other current liabilities | 10,500 | N/A | N/A |
| TOTAL | $17,090 | $N/A | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $17,090 | $N/A | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | N/A | N/A | 22,936 |
| Common Shares | 3,020 | N/A | N/A |
| Retained earnings | 52,580 | N/A | N/A |
| Other shareholders' equity | 5,290 | 0 | 0 |
| TOTAL | $60,890 | $N/A | $N/A |
| Total Liabilities And Equity | $77,980 | $0 | $0 |